| Date | Title | Description |
| 10.01.2025 | Ouro Medicines Raises $120M in Series A Funding | Ouro Medicines, a San Francisco, CA-based biotechnology company developing immune reset therapeutics for people living with chronic immune-mediated diseases, launched with $120m in Series A funding.
The Series A was co-led by TPG Life Scien... |
| 10.01.2025 | The Week’s Biggest Funding Rounds: Data Storage And Lots Of Biotech | 6 Shares Email Facebook Twitter LinkedIn
Want to keep track of the largest startup funding deals in 2024 with our curated list of $100 million-plus venture deals to U.S.-based companies? Check out The Crunchbase Megadeals Board.
This is a w... |
| - | Ouro Medicines | “Ouro Medicines is a biotechnology company developing immune reset therapeutics for people living with chronic immune-mediated diseases.” |